Directive 2001/83/EC
Main European Union (EU) law on pharmaceutical goods
title: "Directive 2001/83/EC" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["health-and-the-european-union", "pharmaceuticals-policy", "european-union-directives", "european-union-directives-by-number", "2001-in-law", "2001-in-the-european-union"] description: "Main European Union (EU) law on pharmaceutical goods" topic_path: "law" source: "https://en.wikipedia.org/wiki/Directive_2001/83/EC" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
::summary Main European Union (EU) law on pharmaceutical goods ::
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 is the main piece of pharmaceutical regulation of the European Union.
It relates to medicinal products for human use in mainly countries that are part of the European Union.
The Directive deals with the disparities between certain national provisions, in particular between provisions relating to medicinal products, which directly affect the functioning of the internal market of the European Union, and regulated the activities of the European Medicines Agency.
References
References
- (28 November 2001). "EUR-Lex - 32001L0083 - EN".
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::